Why Aduhelm, a new Alzheimer's treatment, isn...

Peru’s anchovy industry, the largest single-species fishery in the world, is being rocked by the ongoing El Niño . It’s not the first time the fishery has been impacted by the natural weather phenomenon — El Niño gets its name from Peruvian fishermen. And it’s a stark reminder of ...  Show more

The explosion of GLP-1 drugs has created a gray zone for pregnancy. That recently prompted the American College of Obstetricians and Gynecologists to issue its first ever guidance on the topic. In a twist, the drugs may boost fertility for some, leading to more pregnancies – a ph ...  Show more

When the F.D.A. approved the drug Aduhelm, the first Alzheimer’s treatment to receive the agency’s endorsement in almost two decades, it gave hope to many.

But the decision was contentious; some experts say there’s not enough evidence that the treatment can address cogni ...

After decades without progress, this June a new treatment was approved by the US Food and Drugs Administration - Biogen's Aduhelm. Ivana Davidovic looks into why this process has been so controversial that is now under investigation by a federal watchdog.Aaron Kesselheim, a Harva ...  Show more

Until recently, breakthroughs in treating Alzheimer’s disease were non-existent. But two new drugs have shown promise in moderately slowing memory and thinking problems for people with early-stage disease. While welcoming the idea of a ‘new era’ for treating Alzheimer’s disease, ...  Show more